Immunotoxicity and Immunogenicity of Biopharmaceuticals: Design Concepts and Safety Assessment

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|5|4|293-307

ISSN： 1574-8863

Source： Current Drug Safety, Vol.5, Iss.4, 2010-10, pp. : 293-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 3, 2015-09 ,pp. : 385-400

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunogenicity and its Impact on Benefit/Risk Considerations in the Authorisation of Biopharmaceuticals

By  

Current Drug Safety, Vol. 5, Iss. 4, 2010-10 ,pp. : 287-292

Bentham Science Publishers

Access to resources Recommend Favorite

Pre-Clinical Considerations in the Assessment of Immunogenicity for Protein Therapeutics

By  

Current Drug Safety, Vol. 5, Iss. 4, 2010-10 ,pp. : 308-313

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 805-815

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and Immunogenicity of Combined DTPa-IPV Vaccine for Primary and Booster Vaccination

By Meriste Sirli   Tamm Eda   Willems Paul   Lutsar Irja  

Scandinavian Journal of Infectious Diseases, Vol. 31, Iss. 6, 1999-12 ,pp. : 587-591

Informa Healthcare

Access to resources Recommend Favorite